Well, I did!
Did you ever hear a dream talking?
Well, I did!
Eddy Duchin
Glaxo CEO: Avandia can make a comeback
NEW YORK (Reuters) - A possible tighter U.S. label on GlaxoSmithKline Plc's (GSK.L: Quote, Profile, Research) troubled Avandia drug may not be a disaster for the diabetes treatment, the company's chief executive said on Monday.
When asked whether Avandia could return to its former level of profitability even with a second so-called black-box warning, Glaxo CEO Jean-Pierre Garnier said in a phone interview: "Absolutely. It all depends on what the language is."
FULL LAUGHABLE STORY HERE
No comments: